Asian Business Review

Perovskite cells currently have lifetimes of 5–12 years.

The government is investing over $622.1m to support next-generation medical devices.

This will be driven by IoT, automation, and trade expansion.

If this trend continues, 2025 will be the second-lowest year for approvals.

With Taiwan changing the game when it comes to MICE, we take a look at this dynamic nation and what it has to offer.

Despite government intervention, many persons with disability are still left out of proper coverage.

The diabetes management segment could see the highest CAGR during the period.

APAC will lead this growth.

Hong Kong saw $13.1b (HK$100.5b) in general insurance gross premiums for 2024. 

However, challenges may delay its 82% RE target by 2030.

Solar and onshore wind will lead the clean power capacity expansion.

The majority of executives surveyed plan to increase their investment.

The country’s cumulative solar capacity stood at 125.5GW as of September.

However, the growth of clean power slowed by 7.3% last year.